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Gene targeting: Things go better with Cre
Rulang Jiang and Thomas Gridley
New technologies are changing the way in which gene
targeting experiments are being designed. It is now
becoming possible to analyze gene function in defined
tissues at specific times during the life of a mouse.
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In merely a decade since the first report of targeted gene
disruption in mouse embryonic stem (ES) cells [1], hun-
dreds of genes have been mutated using gene targeting
techniques. Targeted gene disruption has become so
routine that new strains of ‘knockout’ mice are being gen-
erated at the rate of at least several hundred per year. A
large number of these carry null mutations that lead to
obvious developmental defects and frequently cause early
embryonic lethality. While these mutations have provided
valuable information on gene function in embryonic
development, and in some cases on the molecular nature
of human inherited diseases, when mutations cause gross
developmental defects or early embryonic lethality it is
not possible to analyse gene function during later embry-
onic and postnatal stages. Recently, it has been demon-
strated that the Cre/loxP site-specific recombination
system can be used to mutate genes, and thus analyse
their function, at a single developmental stage or in spe-
cific cell types or tissues.
Cre is a bacteriophage P1-encoded recombinase that
catalyzes sequence-specific DNA recombination between
two 34-base-pair repeats, termed loxP sites. While Cre’s
natural function is to dissociate bacteriophage dimers
following replication, it has been shown, in both cultured
mammalian cells and transgenic mice, to excise efficiently
any DNA flanked by two directly repeated loxP sites. In
their pioneering study, Rajewsky and colleagues [2]
demonstrated that transient Cre expression in ES cells effi-
ciently deletes the DNA between two loxP sites that had
been incorporated into the genome by homologous recom-
bination. They went on to develop a ‘conditional’ knockout
strategy, showing that transgenic mice carrying the Cre
gene under the control of a T-cell-specific promoter could
delete genomic DNA flanked by two loxP sites (termed
‘floxed’) specifically in the T-cell lineage [3]. Although the
expected recombination event was not complete in the
target tissue, this report demonstrated the feasibility of
conditionally inactivating genes in specific cell lineages.
In principle, Cre/loxP-mediated gene targeting permits
the inactivation of any gene in any tissue at any stage of
embryonic or postnatal life (Fig. 1). That substantial
progress has already been made in this direction is indi-
cated in three recent papers by Tonegawa and colleagues
[4–6], describing the construction and analysis of trans-
genic mouse lines exhibiting subregion-restricted gene
inactivation in the brain. Tsien et al. [4] used the promoter
from the a-calcium–calmodulin-dependent kinase II
(aCaMKII) gene to drive Cre expression exclusively in the
forebrain. These animals were then crossed to ‘reporter’
mice containing a lacZ gene under the control of the b-
actin promoter; transcription and translation of lacZ were
prevented by an inserted stop sequence, which was
flanked by loxP sites. Using conditional activation of the
lacZ reporter transgene — by deletion of the stop
sequences — as a functional assay of Cre-mediated recom-
bination, Tsien et al. showed that aCaMKII-promoter-
driven Cre expression led to activation of lacZ expression
almost solely in pyramidal cells of the CA1 region of the
hippocampus. 
Several features of the lacZ reporter transgene activation
were of particular interest [4]. Analysis of the time-course
of lacZ activation revealed that Cre-mediated deletion of
the stop sequences in the lacZ reporter did not occur until
the third postnatal week. At this time, neurons in the CA1
region of the hippocampus are in a highly differentiated,
postmitotic state. The recombination event was also
highly efficient, as close to 100% of the neurons in the
CA1 region expressed lacZ. This study demonstrated,
therefore, that Cre-mediated recombination can occur
efficiently in highly differentiated, postmitotic cells. This
is an important point to establish, as it greatly increases
the potential utility of the technique. Only further work
can establish whether Cre-mediated recombination can
occur efficiently in all postmitotic cells.
Tsien et al. [5] then used these aCaMKII–Cre transgenic
mice to study the effects of region-restricted inactivation
of the N-methyl-D-aspartate receptor 1 (NMDAR1) gene,
which encodes an essential subunit of a postsynaptic ion
channel. They crossed the aCaMKII–Cre transgenic mice
to mice containing a floxed NMDAR1 gene, ultimately
generating animals heterozygous for the aCaMKII–Cre
transgene and homozygous for the floxed NMDAR1 gene.
Whereas mice homozygous for a conventional knockout of
the NMDAR1 gene die neonatally [7,8], mice in which the
NMDAR1 gene is inactivated specifically in CA1 cells —
henceforth abbreviated ‘CA1 KO’ mice — grow into
adulthood with no obvious pathologies or behavioral
abnormalities [5]. The CA1 KO mice did, however,
exhibit impaired spatial memory, although their perfor-
mance in nonspatial learning tasks was unimpaired. These
results support the view that NMDA receptor-dependent
long term potentiation in the CA1 region is crucial for the
formation of certain types of memory. 
McHugh et al. [6] studied freely-moving CA1 KO mice by
sophisticated multielectrode recording, in the hope of
gaining further insight into the role of synaptic plasticity
in hippocampus-dependent spatial learning. Their results
indicated that NMDA receptor-mediated synaptic plastic-
ity is necessary for the proper representation of space in
the CA1 region of the hippocampus. The experiments
described in these two papers [5,6] illustrate the value of
region-restricted inactivation of gene expression, as none
of the findings obtained with the CA1 KO mice could be
studied in animals with a conventional knockout of the
NMDAR1 gene, as they die soon after birth.
While Cre/loxP-mediated conditional gene targeting has
clear advantages over conventional gene targeting in ana-
lyzing gene function, its current use is limited by the
availability of well-characterized tissue- or cell-type-spe-
cific promoters  for making Cre transgenic lines. The ver-
satility of Cre/loxP-mediated conditional gene targeting
would be increased if it could be made inducible, as well
as tissue-specific or region-specific. Two groups have
described the successful use of inducible gene targeting
systems in mice. Kühn et al. [9] used an interferon-respon-
sive promoter from the Mx1 gene to drive expression of
the Cre recombinase. These Mx1–Cre mice were then
crossed to mice containing a floxed DNA polymerase b
gene. Efficient deletion of the floxed gene was reported in
a number of tissues of induced mice, although the rate of
background recombination in untreated mice was quite
high in some tissues, perhaps due to the endogenous pro-
duction of interferon in the mice.
Another system for the inducible control of gene
expression in transgenic mice is the tetracycline (tet)
regulatory system developed by Bujard and colleagues
[10,11]. The tet regulatory system is adapted from the
tetracycline-resistance operon of the bacterium Escherichia
coli, and has been modified for transcriptional activation
upon the administration of the antibiotics tetracycline or
doxicycline. The tet activation cassette can be placed
under the control of an organ-specific promoter to obtain
tetracycline-dependent, organ-specific transcriptional acti-
vation [11]. Thus, it should be possible to combine the tet
regulatory system with tissue-specific or cell-type-specific
promoters to obtain Cre-mediated gene inactivation that is
controlled both spatially and temporally.
A second example of inducible gene targeting has been
described recently [12]. As the fusion of the ligand-binding
domain of steroid hormone receptors to a variety of heterol-
ogous proteins can render the activity of these chimeric
proteins hormone-dependent, Feil et al. [12] designed a
chimeric Cre protein whose activity is dependent on a syn-
thetic ligand. They fused a mutated ligand-binding domain
of the human estrogen receptor to the Cre recombinase and
showed that, when expressed in transgenic mice under the
control of a constitutive promoter, the chimeric Cre protein
is activated only by the synthetic ligand 4-hydroxytam-
oxifen, but not by endogenous estradiol. Administration of
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Figure 1
Cre/loxP-mediated gene targeting in
transgenic mice. In this model, the expression
of Cre is driven by a promoter (Pro) that is
only active in the forebrain. loxP sites (red
triangles) have been introduced into introns
between exons 1, 2 and 3 of a target gene by
conventional homologous recombination (see
[3] for details). Mice homozygous for this
allele are mated to mice heterozygous for this
allele that also contain a Cre-expression
transgene (Pro-Cre). Some of the progeny of
this mating will be homozygous for the loxP-
containing allele and heterozygous for the Cre
transgene. These animals will undergo Cre-
mediated deletion of DNA between the loxP
sites in the forebrain. In tissues where the Pre-
Cre transgene is inactive, no deletion occurs.
(Note that, in the Cre-transgene parent, the
loxP-containing allele will also be deleted in
the forebrain.)
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4-hydoxytamoxifen induced Cre-mediated excision of a
floxed target gene in tissues where Cre was expressed,
demonstrating the feasibility of this strategy for inducible
gene inactivation. This strategy could be combined with a
specific promoter to achieve both tissue-specific and tem-
porally controlled gene inactivation. 
Many technical improvements remain to be made in the
various Cre-mediated gene inactivation schemes. In most
cases reported to date, the efficiency of deletion of floxed
genomic DNA is substantially less than 100%, leading to a
mosaic inactivation of the target gene. At present, there-
fore, conditional gene inactivation may be most informa-
tive with genes encoding proteins that function
cell-autonomously — such as transmembrane receptors,
transcription factors and other intracellular proteins. The
conditional inactivation of genes whose products function
non-autonomously — such as ligands or other secreted
proteins — may fail to yield a mutant phenotype unless
the efficiency of Cre-mediated deletion is quite high.
The development of gene targeting technology revolu-
tionized the field of mouse genetics a decade ago. Now,
the combination of the Cre/loxP system, inducible pro-
moters and conventional gene targeting looks set to take
the field a stride further. Progress in tissue-specific and
temporal-specific regulation of gene expression will be
extremely rapid over the next several years, greatly
increasing our understanding of the functional roles of the
genes being studied. Moreover, the progress of these
studies should be fun to observe.
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